Equillium (EQ) Interest & Investment Income (2018 - 2026)
Equillium's (EQ) quarterly Interest & Investment Income came in at $309000.0 in Q1 2026, up 78.61% year-on-year from $173000.0 in Q1 2025, and up 31.49% on a QoQ basis from $235000.0 in Q3 2025.
Equillium (EQ) Interest & Investment Income (2018 - 2026) Analysis & Trends
Equillium (EQ) has 9 years of Interest & Investment Income data on file, last reported at $309000.0 in Q1 2026.
- On a quarterly basis, Interest & Investment Income rose 78.61% year-over-year to $309000.0 in Q1 2026; TTM through Mar 2026 was $666000.0, a 272.07% increase from a year earlier, with the FY2025 full-year figure at -$3000.0, up 80.0% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $309000.0, up from $235000.0 in the prior quarter.
- Over the last five years, Interest & Investment Income for EQ reached as high as $309000.0 in Q1 2026 and fell as low as -$257000.0 in Q4 2022.
- Historically, Interest & Investment Income has averaged $35687.5 across 5 years, with a median of $20000.0 in 2023.
- On a YoY basis, Interest & Investment Income climbed as much as 4433.33% in 2022 and fell as far as 2670.0% in 2022.
- Year by year, Interest & Investment Income stood at -$257000.0 in 2022, then jumped by 111.67% to $30000.0 in 2023, then slumped by 130.0% to -$9000.0 in 2024, then jumped by 2711.11% to $235000.0 in 2025, then surged by 31.49% to $309000.0 in 2026.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $309000.0 in Q1 2026, $235000.0 in Q3 2025, and $122000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Equillium | 242.14 Mn | 242.14 Mn | - | 309,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 309,000.00 |
| Sep 30, 2025 | 235,000.00 |
| Jun 30, 2025 | 122,000.00 |
| Mar 31, 2025 | 173,000.00 |
| Dec 31, 2024 | -9,000.00 |
| Sep 30, 2024 | 21,000.00 |
| Jun 30, 2024 | -6,000.00 |
| Mar 31, 2024 | -22,000.00 |
| Dec 31, 2023 | 30,000.00 |
| Sep 30, 2023 | 19,000.00 |
| Jun 30, 2023 | -36,000.00 |
| Mar 31, 2023 | 96,000.00 |
| Dec 31, 2022 | -257,000.00 |
| Sep 30, 2022 | 130,000.00 |
| Jun 30, 2022 | -54,000.00 |
| Mar 31, 2022 | -180,000.00 |
| Dec 31, 2021 | 10,000.00 |
| Sep 30, 2021 | -3,000.00 |
| Jun 30, 2021 | 13,000.00 |
| Mar 31, 2021 | 26,000.00 |